MedTrace Logo

Study of MRgFUS Exablate Treatment Following the Neuropathic Pain

NCT04649554 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2026-03-20

No results posted yet for this study

Summary

The objective of this study is to capture the change in pain intensity, physical/emotional function, and pain impact for patients diagnosed with neuropathic pain who undergo an Exablate treatment.

Conditions

  • Neuropathic Pain

Interventions

DEVICE

Exablate treatment

Ablation

Sponsors & Collaborators

  • InSightec

    lead INDUSTRY

Principal Investigators

  • Patrice Horwath · InSightec

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-08
Primary Completion
2021-12-31
Completion
2023-08-03

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04649554 on ClinicalTrials.gov